Clinical Trial for Osteoarthritis.

From Research to Revolution.

Are you suffering from the excruciating pain of osteoarthritis? Are you tired of trying various treatment options without finding lasting relief? If so, it’s time to consider a new path – joining this clinical trial for osteoarthritis. Clinical trials offer a unique opportunity to contribute to groundbreaking research while potentially benefiting from cutting-edge treatments and therapies.

By participating in this clinical trial, you become an active participant in the medical revolution. Helping researchers and medical professionals develop new treatments that could improve the lives of millions. Clinical trials provide an avenue for patients to access innovative therapies that are not yet freely available to the general public. Moreover, they offer comprehensive monitoring and care under the guidance of experienced healthcare professionals.

Joining this clinical trial for osteoarthritis may not only provide relief from your symptoms but also contributes to further improving the stem cell treatment of Osteoarthritis. In this trial we will fine tune a new test we have been developing. This test will predict how much patients will respond to stem cell treatment before they are treated. Selecting the correct treatment for each patient is something doctors strive to do every day. This test will make that task easier.

This trial helps you to take control of your health and make a difference in the lives of others. So, don’t wait – seize this opportunity for research-driven revolution and join this clinical trial for osteoarthritis today.

The importance of clinical research in advancing medical treatments

Clinical research plays a crucial role in advancing medical treatments and pushing the boundaries of healthcare. Through rigorous scientific investigations and trials, researchers can gather substantial evidence to evaluate the safety and efficacy of new treatments. Clinical trials provide a platform for testing new therapies, medications, and interventions. This can ensure that they are effective and safe for widespread use. These trials follow strict protocols and guidelines to ensure the reliability and validity of the results.

Clinical research also helps uncover new insights into the mechanisms of diseases and conditions, including osteoarthritis. By participating in a clinical trial, you contribute to expanding scientific knowledge and understanding. You will be providing researchers with valuable data to develop and refine treatments. This research-driven approach is essential for finding innovative solutions and improving the quality of life for patients with osteoarthritis and other medical conditions. Data collected can also often reveal insights that were not obvious before the trial. This may allow us to see things that we could not see before we started the trial.

Collaborators

Graph of Clinical trial for osteoarthritis measuring Multi-Omics
Graph explaining Multi-Omics

Furthermore, clinical research enables collaboration among healthcare professionals, researchers, and participants. Through these partnerships, medical professionals can develop a deeper understanding of patients’ needs, preferences, and responses to different treatments. This collaborative effort ensures that medical advancements are patient-centered, addressing the specific challenges faced by individuals living with osteoarthritis. By joining a clinical trial, you not only benefit personally but also contribute to a larger movement towards improving healthcare outcomes. 

The data we collect in this trial will be shared with our colleagues around the world. As an example serum samples will be sent to Sydney, Australia for further comprehensive Multi-omic analysis. This will support valuable work in progress. This work is already producing key insights across various diseases. It has identified the test that we will refine in this trial. This article by Immy Mobley has a concise explanation of Multi-Omics and how it is used to solve problems.

Understanding osteoarthritis and current treatment options

Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It occurs when the protective cartilage that cushions the ends of bones wears down over time, leading to pain, stiffness, and reduced mobility. While there is no cure for osteoarthritis, various treatment options can help manage symptoms and improve quality of life.

Current treatment options for osteoarthritis range from conservative measures such as physical therapy, lifestyle modifications, and pain management techniques to more invasive interventions like joint replacement surgery. These treatments aim to alleviate pain, improve joint function, and slow down the progression of the disease. However, they may not always provide long-term relief or be suitable for every individual.

Joining a clinical trial for osteoarthritis introduces the possibility of accessing novel treatments and therapies that go beyond the standard options. These trials often explore alternative approaches, such as regenerative medicine, targeted drug therapies, or innovative surgical techniques. By participating in this clinical trial, you will have the opportunity to benefit from a cutting-edge treatment. This could potentially revolutionize the management of osteoarthritis.

The benefits of participating in a clinical trial for osteoarthritis

Participating in a clinical trial for osteoarthritis offers numerous benefits for both individuals and the broader medical community. Firstly, clinical trials provide access to treatments and interventions that may not be available through conventional channels. This means you can explore potential solutions that could significantly improve your symptoms and overall well-being.

Additionally, clinical trials offer comprehensive monitoring and care under the supervision of experienced healthcare professionals. This level of attention ensures that any potential side effects or adverse reactions are promptly addressed, enhancing your safety throughout the trial. The close monitoring also allows researchers to collect valuable data on treatment efficacy and patient outcomes. This further contributes to the advancement of medical knowledge.

Participating in a clinical trial also allows you to play an active role in your own healthcare journey. By joining a trial, you become a valued participant in the research process, helping scientists and medical professionals refine and develop new treatments. Your involvement may lead to discoveries that not only benefit you but also countless others who suffer from osteoarthritis. Making a difference in the lives of others can be a powerful motivator in your decision to participate in a clinical trial.

The risks and considerations of joining a clinical trial

While participating in a clinical trial for osteoarthritis can be an exciting opportunity, it is important to consider the potential risks and drawbacks. Every clinical trial comes with inherent uncertainties, as researchers are testing new treatments and interventions that are not yet fully understood. This means that there may be unknown side effects or outcomes that could impact your health. The safety of using your own adipose derived stem cells to treat Osteoarthritis has been extensively studied. Not only in the laboratory but also in large cohorts of patients.

It is crucial to carefully review the trial’s informed consent document. It outlines the potential risks and benefits associated with participation. The informed consent process ensures that you have all the necessary information to make an informed decision about joining the trial. Additionally, discussing the trial with your healthcare provider can provide further insights and guidance regarding the potential risks and benefits specific to your situation. 

If you want we will provide you with extra copies of the informed consent form so that you may also share this information with your family. If there is anything you do not understand please ask us. Informed consent is not just a form you sign, it is all the information that we give you from day 1 through to signing the consent document. And it does not end there. After your procedure we will continue to answer questions and give you more information as you need it.

Your time commitment

Another consideration is the time commitment required for participating in a clinical trial. Trials typically involve regular visits to the research site, follow-up appointments, and adherence to specific treatment protocols. The formal component of the trial requires follow-up collection of information for 12 months. The value of the trial is significantly enhanced if we are able to gather information from you for many years to come. We hope that we will have contact with you for many years. We ask if you are moving to send us a change of address, change of phone number and change of email. This level of commitment may not be feasible for everyone, so it is essential to evaluate your availability and willingness to commit to the trial requirements.

The Cost of This Clinical Trial

This clinical trial does not receive any financial support from the government. It is funded by the researchers and the patients. This clinical trial is a cohort study. There is no placebo group. Everyone receives the real treament.

This introduces two biases.

  • We do not have a group receiving no treatment that we can compare your results to.
  • Because you are paying money you will be ‘invested’ and more likely to focus on the improvements and downplay any side effects.

Primary Aim of This Clinical Trial for Osteoarthritis

The primary aim of this clinical trial is to fine tune a test we have developed that will predict how much people respond to their own stem cells when treating osteoarthritis. This will allow us to better inform patients so that they can decide before being treated if they want this treatment. Will they get enough benefit? This is known as the risk/benefit ratio and is one of the things we use to assess all treatments in medicine.

The Next Level.

Once we have this test that will will predict who will respond to their own stem cells we will run a new cohort trial excluding evryone we know will not respond. The primary aim of this trial will be to have a 100% response. It is unusual for any treament in medicine to be successful for everyone. Stem cells are no exception. Only by selecting responders can we get a 100% success.

Once we have a 100% response rate we will be able to take the risk of investing into a Placebo controlled Double Blinded Randomised Clinical Trial.

Why do Clinical Trials Fail?

Many clinical trials fail. The definition of a failed trial is not the Yes/No answer. A No answer, if accurate, is very valuable

A trial fails if it is not conclusive or returns an incorrect answer. The most common reasons lie in the trial design.

  • The main (Primary) question that the trial seeks to answer is the question by which the trial will be deemed a success or a failure. Secondary questions can be explored but if the primary question has failed the secondary questions will be weakened.
  • Asking the wrong question. Multiple case reports and small series lead to larger chort studies. These studies help us to work out what the correct question or questions are. One of the outcomes we explored was ‘Is red meat bad for you?’ In the study the question was asked as ‘How much red meat do you eat?’ This question was confounded because it included ‘Bad’ red meat and ‘Good’ red meat. When we realised that we needed to ask for unprocessed and processed red meat comsumption separately we were able to get the correct answer.
  • Not treating the whole patient. Total Joint Replacement can remove pain from a single joint but if multiple joints are involved it can be difficult to measure improvement in one joint when pain is coming from multiple areas. Most of the patients will also have pain from Central Sensitization which will not improve with Total Joint Replacement. This is why only 53% of total joint replacement patients acheive PASS.
  • Not finding enough patients: If the inclusion/exclusion criteria are very narrow there may not be enough patients in the population who have all the attributes that the researchers want.
  • Inadequate study design and planning.
  • Insufficient sample sizes: How many patients need to be treated to be certain that the treatment improved them and that it was not a random change in their life or some other variable. If the difference that the treatment makes is small we will need a lot of patients to show the difference between the treated and the not treated group. If the treatment has a big effect we will see the change in the treated group with smaller numbers. The MCID is a measure of how big the treatment effect is for each patient. See below.
  • Flawed methodology,
  • Improper study endpoints. The endpoint is the change in symptom (Such as pain) or the change in a laboratory measurement (such as blood sugar or blood cholesterol). The endpoint needs to be easy to measure and significant. The minimal clinically important difference (MCID) is the smallest change in a treatment outcome that an individual patient would identify as important and which would indicate a change in the patient’s management.
  • Defining the most desirable question and endpoint. Losina and Katz show that measuring improvement in pain and function after Total Joint Replacement is useful for comparing the different implant chosen but Patient Acceptable Symptom State (PASS) is more meaningful at a public policy level. Their paper explores the balance between measuring the change in one joint as opposed to measuring the state of symptoms in the whole person. (The Patient Acceptable Symptom State.) Only 53% of patients who have total joint replacement acheive a positive PASS.
  • A high drop-out rate.
    • Choosing patients who are committed to the trial and have the time can be difficult.
    • If the treatment has significant side effects patients will find it more difficult to continue to the end.
    • Non-compliance: it is imperative that the patients and the researchers follow the protocol carefully. Non-compliance will eliminate them from the trial weakening the statistical power of the study.

The impact of clinical trials on future treatments for osteoarthritis

Clinical trials play a pivotal role in shaping the future treatments for osteoarthritis. By participating in a trial, you contribute to the body of knowledge that informs medical advancements and therapeutic approaches. The data collected from clinical trials helps researchers identify trends, assess treatment efficacy, and understand how different populations respond to specific interventions. This allows us to practice personalized medicine. Selecting the right treatment for each patient.

Furthermore, the success of clinical trials can lead to the approval and widespread adoption of new treatments. Positive trial results may pave the way for regulatory agencies to grant approvals. This allows healthcare insurers to approve payment allowing these treatments to become accessible to a broader population. Your participation in a clinical trial can have a lasting impact on the lives of individuals with osteoarthritis. Potentially providing them with more effective and innovative treatment options in the future.

The process of enrolling in a clinical trial 

You will need to contact the research team to express your interest and inquire about the enrollment process. We will provide you with detailed information about the trial, including

  • the purpose of the trial,
  • treatment procedures,
  • potential risks, and
  • anticipated time commitment.

We will also assess your eligibility based on specific criteria such as age, medical history, and severity of osteoarthritis symptoms.

If you meet the eligibility criteria and decide to proceed, you will be asked to provide your informed consent. This process involves thoroughly reviewing the consent form, which outlines the trial’s objectives, procedures, potential risks, and benefits. It is essential to ask any questions you may have and seek clarification before signing the form.

Once you have provided informed consent, you will begin the trial. You will have completed several trial forms as part of the assessment to see if you are eligible.  This will include the baseline assessments, such as measuring your pain, loss of function, stage of osteoarthritis and subtype. Following treatment you will have regular follow-up visits. Some of these can be conducted via telephone or email. Throughout the trial you will receive ongoing support and monitoring from the research team, who will closely monitor your progress and ensure your safety. 

Eligibility criteria for clinical trials

Each clinical trial has specific eligibility criteria that participants must meet to ensure the trial’s scientific integrity and participant safety.

While the criteria may vary depending on the study, the factors that are important to us include

  • age,
  • gender,
  • medical history,
  • free from signs of dementia
  • current health status, and
  • severity of osteoarthritis symptoms.

It is important to note that not everyone will meet the eligibility criteria for our particular clinical trial. However, there are often multiple trials available, each with its own set of criteria. Even if you don’t qualify for our trial, it is worth exploring other opportunities that may be better suited to your circumstances. Discussing your options with your healthcare provider can help identify trials that align with your needs and increase your chances of finding a suitable study.

Conclusion: Making an informed decision about joining our clinical trial for osteoarthritis

Joining a clinical trial for osteoarthritis can be a transformative experience, offering the potential for improved symptom management, access to innovative treatments, and the opportunity to contribute to medical advancements. However, it is essential to approach the decision with careful consideration. Ensure that you have all the necessary information to make an informed choice.

Understanding the importance of clinical research in advancing medical treatments and the current treatment landscape for osteoarthritis can help you evaluate the potential benefits of participating in a clinical trial. It is equally important to weigh the potential risks and considerations, such as unknown side effects and time commitments, before making your decision. Clinical researchers commit a very large amount of their time and risk a large part of their careers to make sure that this trial will be good for you, for our country and for their career. Can you return that committment. Can you give your time to complete all the protocols that will define the success of this trial.

By participating in our clinical trial, you become an active participant in the medical revolution, helping shape the future of osteoarthritis treatments. Take control of your health. Contribute to scientific knowledge, and potentially benefit from cutting-edge therapies by joining  our clinical trial for osteoarthritis today. Don’t miss the opportunity to make a difference in your own life and in the lives of others.

If you would like more information send us an email at enquiries.clinica@gmail.com

Scroll to Top